Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma

Ads

You May Also Like

NewLink Genetics to Participate in Jefferies Healthcare Conference

AMES, Iowa, June 02, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced ...

FDA Approves Expanded Indication for Medtronic Freezor® Xtra Cryoablation Catheter

Demonstrated Safe and Effective for Treating Patients with Abnormal Heart Rhythm of AVNRT DUBLIN ...

TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing

WALTHAM, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused ...